Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Next-generation Sequencing

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Genetic Screens

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...

Genomics

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...

Behavioral Genetics and Its Designs

Behavioral Genetics and Its Designs

Behavior genetics explores how genetic inheritance influences human behavior. It focuses on how genes, passed from parents to offspring, contribute to the development of behavioral traits and tendencies. This branch of genetics seeks to understand the complex interplay between inherited genetic factors and environmental influences in shaping our behaviors.
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Activation of the endocytosis pathway stratifies subtypes and therapeutic sensitivity in colorectal cancer.

Research square·2026

Same author

Liver single-nucleus multiome profiling reveals cell-type mechanisms for cardiometabolic traits.

American journal of human genetics·2025

Same author

GABAergic signaling contributes to tumor cell invasion and poor overall survival in colorectal cancer.

Oncogene·2025

Same author

Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: A combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance).

European journal of cancer (Oxford, England : 1990)·2025

Same author

Novel treatment-specific causal biomarkers for colorectal cancer by omics integration.

NAR genomics and bioinformatics·2025

Same author

Genetic effects on chromatin accessibility uncover mechanisms of liver gene regulation and quantitative traits.

Genome research·2025

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Identification of Functionally-Relevant Lentivirus Integration Sites in an Insertional Mutagenesis Cell Library

Identification of Functionally-Relevant Lentivirus Integration Sites in an Insertional Mutagenesis Cell Library

Published on: January 10, 2025

Insights, challenges, and future directions in irinogenetics.

Tae Won Kim¹, Federico Innocenti

¹Section of Oncology, Department of Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea.

Therapeutic Drug Monitoring

|May 29, 2007

Summary

Irinotecan

Area of Science:

Pharmacogenetics
Oncology
Drug Metabolism

Background:

Irinotecan is a key chemotherapy for colorectal and lung cancers.
Severe toxicities like neutropenia and diarrhea limit its use.
SN-38, the active metabolite, is detoxified by UGT1A1 enzyme.

Purpose of the Study:

To review the pharmacogenetics of irinotecan (irinogenetics).
To summarize current research and identify knowledge gaps.
To highlight irinogenetics as a model for personalized medicine.

Main Methods:

Review of existing literature on irinotecan pharmacogenetics.
Analysis of UGT1A1 gene variants and their impact on irinotecan metabolism.
Examination of clinical studies linking genetic variations to irinotecan toxicity.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Infinium Assay for Large-scale SNP Genotyping Applications

Infinium Assay for Large-scale SNP Genotyping Applications

Published on: November 19, 2013

Related Experiment Videos

Last Updated: Jul 14, 2026

Identification of Functionally-Relevant Lentivirus Integration Sites in an Insertional Mutagenesis Cell Library

Identification of Functionally-Relevant Lentivirus Integration Sites in an Insertional Mutagenesis Cell Library

Published on: January 10, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Infinium Assay for Large-scale SNP Genotyping Applications

Infinium Assay for Large-scale SNP Genotyping Applications

Published on: November 19, 2013

Main Results:

UGT1A1 variants, particularly UGT1A1*28, significantly impact irinotecan pharmacokinetics and toxicity.
UGT1A1*6 is associated with irinotecan toxicity risk in Asian populations.
FDA label revisions reflect the clinical significance of UGT1A1 genotyping.

Conclusions:

Pharmacogenetics of irinotecan (irinogenetics) is crucial for personalized cancer therapy.
Understanding UGT1A1 variations enables prediction and mitigation of irinotecan toxicities.
Further research is needed to fully elucidate irinogenetics and optimize treatment strategies.